Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487240 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 387
- Enrollment target
NCT00487240 is a Phase 3 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 387 participants.
The verdict
NCT00487240, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 387 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the efficacy and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.
Interventions
- DRUG Insulin Lispro Protamine Suspension
- DRUG Insulin Levemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487240
The ClinicalTrials.gov registry entry for NCT00487240 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 387 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin Lispro Protamine Suspension is the first listed.
NCT00487240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487240 about?
NCT00487240 is a clinical study titled "Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes". The purpose of this study is to examine the efficacy and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for sequentially testing the s...
What is the current status of trial NCT00487240?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 387 participants. The study started on 2007-06. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00487240?
The interventions under investigation include: Insulin Lispro Protamine Suspension (DRUG), Insulin Levemir (DRUG).
Who is sponsoring clinical trial NCT00487240?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.